Media ReleaseEfti in combination with pembrolizumab and radiotherapy demonstrates significant efficacy in the neoadjuvant setting in patients ...

Vaccinex has global commercial and development rights to pepinemab and is the sponsor of the KEYNOTE-B84 study which is being performed in collaboration with Merck Sharp & Dohme Corp, a subsidiary of ...

CEL-SCI Corporation today announced that in a recent meeting the U.S. Food and Drug Administration (FDA) concurred with the Company's approach to patient selection using low PD-L1 tumor expression in ...

Dose-limiting toxicities were observed in the combination arm of the Phase 1b PYNNACLE trial evaluating rezatapopt and Merck's anti-PD-1 therapy KEYTRUDA ® (pembrolizumab ... type advanced solid ...

Posters will be made available on the Kineta website following presentations at the conference. KEYTRUDA ® is a registered trademark ... and a preclinical monoclonal antibody targeting CD27. For more ...

Merck & Co/MSD has won approval in the US for PD-1 inhibitor Keytruda as a treatment for hepatocellular carcinoma (HCC), the most common form of liver cancer, opening up another front in its ...

The New Digital Frontiers of Information: "Media and Information Literacy for Public Interest Information" This year’s theme highlights the importance of equipping people with critical thinking ...

The Business Information Technology (BIT) major is designed to provide students with expertise in the development and use of computer systems and quantitative modeling techniques for solving business ...

The posters were not created or installed by the city of New York, and photographs of them were actually from 2018. In October 2024, ahead of the U.S. presidential elections and as Republican ...

Poster figures should not be overly complicated, cluttered, or include too much information. Before sitting down to make their figures, scientists should first identify key pieces of information that ...

Keytruda, a cancer treatment drug, has achieved $25 billion in global sales. Its mechanism boosts the immune system to fight cancer. In India, its high cost limits access. With patents expiring soon, ...

Abhishek Bachchan channels a grumpy-cat look in the first look poster of Shoojit Sircar’s I Walk to Talk. The film is the story of a pot-bellied NRI man and his relationship with his daughter.